![5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine structure](/static/products/672/672887-45-5.png)
5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine
TL;DR: 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine (CAS 672887-45-5) is a chemical compound with molecular formula C30H26N2O3 and molecular weight 462.19 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
5-(4-methoxy-3-phenylmethoxyphenyl)-2-phenyl-5,10b-dihydro-1H-pyrazolo[1,5-c][1,3]benzoxazine
Also Known As: 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine, 5-(3-(benzyloxy)-4-methoxyphenyl)-2-phenyl-5,10b-dihydro-1H-benzo[e]pyrazolo[1,5-c][1,3]oxazine, 5-(4-methoxy-3-phenylmethoxyphenyl)-2-phenyl-5,10b-dihydro-1H-pyrazolo[1,5-c][1,3]benzoxazine
| Molecular Formula | C30H26N2O3 |
|---|---|
| Molecular Weight | 462.19 g/mol |
| LogP | 6.5165 |
| Topological Polar Surface Area | 43.29 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Exact Mass | 462.19434 |
| Heavy Atoms | 35 |
| Complexity | 1354.6576 |
Chemical Identifiers
| CAS Number | 672887-45-5 |
|---|---|
| SMILES | COC1=C(C=C(C=C1)C2N3C(CC(=N3)C4=CC=CC=C4)C5=CC=CC=C5O2)OCC6=CC=CC=C6 |
Product Overview
5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine (CAS 672887-45-5), with molecular formula C30H26N2O3 and molecular weight 462.19 g/mol. IUPAC: 5-(4-methoxy-3-phenylmethoxyphenyl)-2-phenyl-5,10b-dihydro-1H-pyrazolo[1,5-c][1,3]benzoxazine.
Chemical Property Profile of 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine
Property Insights of 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine
The XLogP value of 6.5165 indicates that 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 43.29 Ų, 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine has 0 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), which may warrant consideration for formulation optimization.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine?
The CAS number of 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is 672887-45-5.
What is the molecular formula of 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine?
The molecular formula of 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is C30H26N2O3.
What is the molecular weight of 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine?
The molecular weight of 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is 462.19 g/mol.
Where can I buy 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine?
You can request a quote for 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine?
Yes, KEHONG BIO provides custom synthesis services for 5-[3-(benzyloxy)-4-methoxyphenyl]-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.